GVR Report cover ENT Devices Market Size, Share & Trends Report

ENT Devices Market Size, Share & Trends Analysis Report By Product (Hearing Aids, Hearing Implants, Diagnostic Devices, Surgical Devices, Nasal Splints), By Region, And Segment Forecasts, 2021 - 2028

  • Report ID: 978-1-68038-477-2
  • Number of Pages: 141
  • Format: Electronic (PDF)
  • Historical Range: 2016 - 2019
  • Industry: Healthcare

Report Overview

The global ENT devices market size was valued at USD 20.7 billion in 2020 and is estimated to expand at a compound annual growth (CAGR) of 4.7% from 2021 to 2028. The rising geriatric population, increasing prevalence of ENT-related disorders, increasing penetration of minimally invasive ENT procedures are among the key trends stimulating market growth. Technological advancements also play an important role in the growth of the market.

U.S. ENT devices market size, by product, 2018 - 2028 (USD Billion)

Demand for advanced ENT devices and systems, such as robot-assisted endoscopes, in developing economies is low due to high cost, as their use is concentrated to developed economies, such as the U.S. However, increasing healthcare spending by other governments and a rise in per capita income are anticipated to significantly improve market penetration. Sales are expected to increase at a rapid pace in developing economies due to the high incidence of ENT diseases, such as hearing loss and sinusitis, and an increase in efforts to provide better access to healthcare facilities in these regions.

Hearing loss/impairment has become one of the most common conditions in patients, especially in industrialized countries. According to the WHO, there are over 460 million people worldwide, i.e., around 5% of the world’s population, living with disabling hearing loss, which is expected to increase to over 900 million or 1 in every 10 people by 2050. Two of the main reasons for this are growing life expectancy and increasing noise pollution, which means more cases of age-related hearing loss. Infections such as measles, middle ear infection, or meningitis are also common causes of hearing loss in low-income countries. Moreover, chronic inflammation, noise exposure, vascular disorders, physiological aging of the ear, and genetic susceptibility may cause hearing impairment.


COVID-19 ENT Devices Market Impact: 6.0 % decline from 2019 to 2020

Pandemic Impact

Post COVID Outlook

In the worst-hit months of 2020, mass closure of ENT clinics and termination of elective surgical procedures in hospitals drove down sales of ENT medical devices.

Resumption of surgical procedures and business operations of companies within the given guidelines is expected to boost growth in the coming years.

The restriction on movement enforced in most markets harmed the entire industry. For instance, audiology stores, the primary consumer channel of hearing care services and products, are either operating with significantly reduced hours or have been shut.

Market conditions varied greatly across regions, with ENT-related surgery volumes recovering quickly in the U.S., China, Germany, & Australia and more slowly in Spain, the U.K., and Italy. As volumes of ENT-related surgeries grow, demand for ENT devices is also expected to rise.


ENT devices for minimally invasive procedures are dominated by companies such as Karl Storz, which offers HD video rhino-laryngoscope that can be used for visualization of nose, pharynx, & larynx in HD image quality. Ambu, Inc. also offers single-use rhino-laryngoscope, which provides ENT specialists an alternative to reusable scopes. In March 2019, the company received CE Mark for Ambu aScope 4 RhinoLaryngo Slim.

Product Insights

In 2020, the diagnostic ENT devices segment dominated the market and accounted for the largest revenue share of 28.3%. This growth is due to the availability of several products and the presence of major market players. Some of the key players in the market offering diagnostic ENT devices are Hill-Rom.; Karl Storz GmbH & Co KG; MAICO Diagnostics GmbH; BioMed Jena GmbH; PATH medical GmbH; Fujifilm Corporation; Ambu A/S Smith; Nephew PLC.; iHEARmedical, Inc.; Veran Medical Technologies; and Hedera Biomedics S.r.l.

New product launches and mergers and acquisitions are prominent growth strategies adopted by these players. For instance, in July 2017, PENTAX Medical-a HOYA Group division and Shanghai Aohua Photoelectricity Endoscope Co., Ltd. announced a joint venture to create products in the field of flexible medical endoscopy.

However, the hearing aids segment is likely to grow at the fastest rate during the forecast period. This can be attributed to the entry of various players, increasing adoption of these devices, and technological advancements due to an increase in investment by market players on R&D. For instance, in February 2020, Starkey Hearing Technologies announced the launch of Livio Edge AI. It combines the best of both technologies-sound processing and sound quality-for challenging listening environments.

Regional Insights

North America dominated the market for ENT devices and accounted for the largest market share of 36.0% in 2020. This can be attributed to the high prevalence of ENT-related disorders in the region; increased demand for hearing care devices; and presence of large hospitals chains, highly equipped ambulatory facilities, and a significant target population. In addition, the local presence of key market players, supportive government regulations for portable medical devices, and high adoption of advanced technology are also key factors for the dominance in the market.

In Europe, the market accounted for the second-largest revenue share in 2020. The region has high product penetration for hearing aids due to well-established healthcare infrastructure and high patient awareness levels. Asia Pacific is anticipated to grow at the fastest rate during the forecast period due to increasing awareness about early diagnosis of diseases, growing healthcare expenditure, and rising investment by market players. Olympus Corporation, a Japan-based company, in May 2018, introduced ENF-VT3, a rhino-laryngo videoscope, to integrate 4-direction angulation capability.

Global ENT devices market share, by region, 2020 (%)

Singapore, Thailand, Australia, and South Korea are some of the emerging countries in the Asia Pacific region. Technological advancements, such as wireless, real-time monitoring, increase in healthcare spending in the Asia Pacific region, and support from regulatory bodies are anticipated to promote the growth of the ENT devices market.

Key Companies & Market Share Insights

Acquisitions, partnerships, and the launch of new products are key strategies adopted by market players. In March 2020, WS Audiology announced the launch of WIDEX MOMENT-the first generation of hearing aids that sound natural. This is accomplished through Widex's patented ZeroDelay Technology. In September 2019, Cochlear Limited and GN Hearing collaborated with Google & announced support for direct streaming from Android devices to hearing devices, using Bluetooth Low Energy (BLE). Some of the prominent players in the ENT devices market include:

  • Demant A/S

  • Sonova

  • Ambu A/S

  • Pentax Medical

  • Karl Storz

  • Olympus Corporation

  • Richard Wolf Gmbh

  • Widex

  • Cochlear Ltd.

  • Sivantos, Inc.

  • Starkey Hearing Technologies

  • Gn Resound A/S

  • Rion Co., Ltd.

  • Welch Allyn

  • Atos Medical AB

ENT Devices Market Report Scope 

Report Attribute


Market size value in 2021

USD 21.5 billion

Revenue forecast in 2028

USD 29.6 billion

Growth Rate

CAGR of 4.7% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Brazil; Mexico; South Africa

Key companies profiled

Demant A/S; Sonova; Ambu A/S; Pentax Medical; Karl Storz; Olympus Corporation; Richard Wolf Gmbh; Widex; Cochlear Ltd.; Sivantos, Inc.; Starkey Hearing Technologies; Gn Resound A/S; Rion Co., Ltd.; Welch Allyn; Atos Medical Ab

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global ENT devices market report on the basis of product and region:

  • Product Outlook (Revenue, USD Million, 2016 - 2028)

    • Diagnostic ENT Devices

      • Rigid Endoscopes

        • Sinuscopes

        • Otoscopes

        • Laryngoscopes

      • Flexible Endoscopes

        • Bronchoscopes

        • Laryngoscopes

        • Nasopharyngoscopes

      • Robot Assisted Endoscope

      • Hearing Screening Device

    • Surgical ENT Devices

      • Radiofrequency handpieces

      • Otological Drill Burrs

      • ENT Hand Instruments

      • Sinus Dilation Devices

      • Nasal Packing Devices

    • Hearing Aids

    • Hearing Implants

    • Nasal Splints

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • Japan

      • India

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa (MEA)

      • South Africa

Frequently Asked Questions About This Report




This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.